EUVIMED · CrossrefZeitschrift
Molecular Therapy Advances
ISSN 3117-387X · Elsevier BV
Neueste Artikel
LVV SMRTcap reveals extensive proviral variation in lentiviral vector-transduced CAR T cells
AAV-mediated genome targeting of the GLA cDNA in newborn and juvenile Gla KO mice achieves long-term correction of Fabry disease
A dual-switch safety system enables safety controllability and high-efficiency enrichment for T cell immunotherapy
A novel technology-driven enzyme replacement therapy for Pompe disease
SGLT1 inhibition in cystic fibrosis: From preclinical evidence to clinical potential
Untangling the complexity of adenovirus retargeting—From design to efficacy
The longer, the better? Optimizing dystrophin constructs for cardiac gene therapy in Duchenne muscular dystrophy
Optimized GENE TARGET framework characterizes barriers to therapeutic development for monogenic neurodevelopmental disorders
Development of protein expression and enzymatic activity potency assays for mRNA therapeutic development: A case study using GSDIII mRNA-LNP
Long-read genome sequencing reveals complex variability in lentiviral provirus insertions in clonal CD19 CAR-T VCN reference cell lines
AAV-delivered TNF-α inhibitors for the treatment of non-infectious uveitis
Subcutaneous administration of adipose-tropic leptin gene therapy for congenital generalized lipodystrophy
Baculovirus helper functions during recombinant adeno-associated virus production in insect cells for gene therapy applications
VP2-TALE fusions increase AAV2 capsid filling with payload bearing cognate TALE target sequences as determined by qPCR/ELISA
NIS reporter gene PET imaging reveals expansion kinetics and localization of anti-CD20 CAR-T in mice and nonhuman primates
Disarming oxidized lipids: AAV-delivered antibody neutralization as an emerging strategy against ALS
Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses
AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice
A dual-function adenoviral system for transgene delivery and gene editing for host factor studies in a murine model of SARS-CoV-2 infection
Safe and efficacious gene therapy for sialidosis: From monocistronic to bidirectional AAV vectors encoding Neu1 and Ctsa
Combination in vivo HSPC gene therapy for HIV by CCR5 knockout and decoy receptor
PMD: A Geometric Coordinate for Clonal Dominance in Gene and Cell Therapy
A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in mice
AAV6-Gsx1 promotes sustained functional recovery in a pilot long-term study after contusion spinal cord injury
Programmable Transcriptional Activation in Human iPSC-Derived Hepatocyte Metabolic Stress Culture for Target Discovery
An integrated enzymatic and computational pipeline for quantifying off-target base-editing
Assessing Germline Transmission Risk and First-in-Human Dose Selection for In Vivo Gene Therapies
Cryo-EM Mapping of Human Neutralizing Antibodies Reveals 3-fold Antigenic “Hotspot” on the AAV2 Capsid
A Novel Human iPSC-derived Liver Model for In Vitro Assessment of AAV Gene Therapies
Automated Ex Vivo Processing Enables Lentiviral Transduction and Preserves Stemness in Human CD34+ Hematopoietic Stem and Progenitor Cells
EUVIMED